ASBMR 2015

Denosumab Beats Zoledronic Acid in Women Previously Treated With Bisphosphonates

Denosumab Beats Zoledronic Acid in Women Previously Treated With Bisphosphonates

By

Denosumab increases BMD more than zoledronic acid in women who were treated with bisphosphonates.

Physician Prescribing Patterns for Bisphosphonate Regimens

Physician Prescribing Patterns for Bisphosphonate Regimens

By

Many express a preference for weekly or monthly oral bisphosphonate regimens.

Oral Bisphosphonates Lowered Mortality, Subsequent Fracture Risks

Oral Bisphosphonates Lowered Mortality, Subsequent Fracture Risks

By

Oral bisphosphonates appear to lower the risk for subsequent fracture and mortality after fracture.

FRAX Scores May Need Adjustment for Patients With Type 2 Diabetes

FRAX Scores May Need Adjustment for Patients With Type 2 Diabetes

By

Patients with type 2 diabetes may be at higher risk for fracture than indicated by FRAX score.

Study Identifies Barriers to Osteoporosis Prevention

Study Identifies Barriers to Osteoporosis Prevention

By

Many older people unconcerned about or unaware of osteoporosis.

Race May Affect Atypical Femur Fracture Risk in Women Taking Bisphosphonates

Race May Affect Atypical Femur Fracture Risk in Women Taking Bisphosphonates

By

Asian women taking bisphosphonates may have a higher risk for atypical femur fracture than white women.

Bisphosphonates May Improve Bone Balance in Postmenopausal Women

Bisphosphonates May Improve Bone Balance in Postmenopausal Women

By

Treatment improved bone balance and reduced bone turnover.

Romosozumab Boosted Bone Strength in Postmenopausal Women

Romosozumab Boosted Bone Strength in Postmenopausal Women

By

The sclerostin inhibitor may increase bone strength at the spine and hip in postmenopausal women.

Asfotase Alfa May Significantly Benefit Children with Hypophosphatasia

Asfotase Alfa May Significantly Benefit Children with Hypophosphatasia

By

Treatment over 5 years appears to be safe and effective.

Clinical Variables Linked to Trabecular Bone Score

Clinical Variables Linked to Trabecular Bone Score

By

Variables included gender and age.

Odanacatib Increased Bone Density in Women With Osteoporosis

Odanacatib Increased Bone Density in Women With Osteoporosis

By

Selective oral cathepsin K inhibitor odanacatib improved bone density in older women with osteoporosis.

Parathyroid Hormone for Hypoparathyroidism May Be Effective Over Long Term

Parathyroid Hormone for Hypoparathyroidism May Be Effective Over Long Term

By

PTH (1-84) for 7 years is linked to reduced calcium and calcitriol supplementation.

Denosumab for 10 Years Is Safe, Effective in Older Women

Denosumab for 10 Years Is Safe, Effective in Older Women

By

Denosumab treatment for up to 10 years is linked to persistent reduction in bone turnover and increased BMD.

High Doses of Vitamin D May Increase Risk for Falls

High Doses of Vitamin D May Increase Risk for Falls

By

Higher doses of vitamin D may actually do more harm than good in elderly women.

Drinking Tea May Help Lower Fracture Risk

Drinking Tea May Help Lower Fracture Risk

By

Three or more cups per day may lower risk for fracture.

Bisphosphonates May Benefit Postmenopausal Women With Diabetes

Bisphosphonates May Benefit Postmenopausal Women With Diabetes

By

Fracture risk may be lower with bisphosphonates in women with diabetes.

Abaloparatide Reduced Fracture Incidence in Postmenopausal Women

Abaloparatide Reduced Fracture Incidence in Postmenopausal Women

By

Fracture risk may be significantly lower in postmenopausal women with abaloparatide vs. teriparatide or placebo.

Trabecular Bone Score, HbA1c May Predict Fractures in Type 1 Diabetes

Trabecular Bone Score, HbA1c May Predict Fractures in Type 1 Diabetes

By

While these may serve as predictors, bone mineral density may not.

Sign Up for Free e-Newsletters

CME Focus